Home / Pharmaceutical company intelligence
Cunningham Pharmaceuticals (Pvt.) Ltd. logo
Pharmaceutical company intelligence

Cunningham Pharmaceuticals (Pvt.) Ltd.

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer incorporated in 2012 with cGMP manufacturing across general, cephalosporin, ophthalmic and psychotropic sections.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check27 Aug 2026Latest source-check date across this published portfolio
Latest effective price date1 Jul 2024Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
81, Sundar Industrial Estate, Raiwind Road, Lahore, Pakistan
Phone
+92 42 35297381; +92 42 35297386
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000840 Cunningham Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000840 94 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx94public portfolio records represented
REG78unique registrations represented
IDX94indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR94current validated price records
G37generic molecules in indexed catalogue
DF5dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage98%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixCunningham Pharmaceuticals (Pvt.) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/cunningham-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Anti-infectives46 · 49%Hematology & thrombosis10 · 11%Cardiovascular8 · 9%CNS & mental health8 · 9%Oncology & immunology6 · 6%Gastrointestinal & hepatology5 · 5%Fluids & supportive care3 · 3%Other therapeutic areas8 · 9%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioCunningham Pharmaceuticals (Pvt.) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/cunningham-pharmaceuticals-pvt-ltdGenerated 24 Sep 202694presentationsTablet43 · 46%Injection28 · 30%Capsule16 · 17%Suspension5 · 5%Pessary2 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionCunningham Pharmaceuticals (Pvt.) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/cunningham-pharmaceuticals-pvt-ltdGenerated 24 Sep 202692comparable productsBelow peer median70 · 76%Near peer median14 · 15%Above peer median8 · 9%Company median price position-9.3%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsCunningham Pharmaceuticals (Pvt.) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/cunningham-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Pharmasol (Pvt) Ltd.30 shared81% overlapMediate Pharmaceutical Pvt Ltd25 shared68% overlapNabiqasim Industries (Pvt) Ltd.,24 shared65% overlapNeutro Pharma (Pvt.) Ltd.,24 shared65% overlapNovaMed Pharmaceuticals(Pvt.)Ltd24 shared65% overlapM/s. Genix Pharma (Pvt) Ltd.23 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives46 products · 49%
Hematology & thrombosis10 products · 11%
Cardiovascular8 products · 9%
CNS & mental health8 products · 9%
Oncology & immunology6 products · 6%
Gastrointestinal & hepatology5 products · 5%
Fluids & supportive care3 products · 3%
Vitamins, minerals & nutrition3 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins16 products · 17%
Anticoagulants8 products · 9%
Antiepileptics8 products · 9%
First-generation cephalosporins7 products · 7%
Fluoroquinolone antibacterials6 products · 6%
Macrolide antibacterials5 products · 5%
Antivirals3 products · 3%
Fluids, electrolytes & diluents3 products · 3%
Formulation footprint

Dosage forms

Tablet43 products
Injection28 products
Capsule16 products
Suspension5 products
Pessary2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 ImroxavirRivaroxaban 8presentations 10 mg, 15 mg, 20 mg · Tablet #2 LorictamLevetiracetam 8presentations 1 g, 250 mg, 500 mg, 750 mg · Tablet #3 AxitrimCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #4 CulexCephalexin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #5 AfazoleCefazolin 3presentations 1 g, 500 mg · Injection #6 AquajectWater for Injection 3presentations 10 mL, 10 mL presentation, 5 mL · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median7076% of comparable products
Near market median14within ±5% of median
Above market median89% of comparable products
Lowest-price equivalents9ties included
Company median price position -9.3% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Cuket 50 mgKetamine · Injection · 10ml PKR 17.54/mL-27.9% vs market median Aquaject 10 mLWater for Injection · Injection · 100's PKR 16.56/vial/unit-27.7% vs market median Aquaject 10 mL presentationWater for Injection · Injection / diluent · 1's PKR 18.00/vial/unit-22.5% vs market median Afazole 1 gCefazolin · Dry powder for injection · 1's PKR 170.61/vial/unit-21.9% vs market median Lorictam 750 mgLevetiracetam · Tablet · 30's PKR 102.59/tablet-21.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.257 products · 102 generics 30shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 25shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 24shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 24shared generics NovaMed Pharmaceuticals(Pvt.)Ltd187 products · 62 generics 24shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 23shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers78Distinct registrations among indexed, published, presentation-validated products only
Verified price observations94
Products with a verified price94
Products with multiple price observations0
Source records with multiple versions92
Latest portfolio source check27 Aug 2026
Latest effective price date1 Jul 2024
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

78 unique registration(s) · 94 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Afazole Cefazolin 500 mg Powder for injection 1's 084509 PKR 102.37 PKR 102.37/vial/unit No comparator
Afazole Cefazolin 500 mg Dry powder for injection 1's 084509 PKR 102.37 PKR 102.37/vial/unit Near median
Afazole Cefazolin 1 g Dry powder for injection 1's 084510 PKR 170.61 PKR 170.61/vial/unit 22% below median
Ajicin Azithromycin 250 mg Capsule 6's 106141 PKR 243.95 PKR 40.66/capsule 18% below median
Ajicin for Azithromycin 200 mg/5 mL Suspension 15ml 107088 PKR 263.09 PKR 17.54/mL 20% below median
Ajimox Moxifloxacin 400 mg Tablet 5’s 100631 PKR 810.39 PKR 162.08/tablet 12% below median
Apniton 200 Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 106140 PKR 12,245.56 PKR 102.05/tablet 6% above median
Aquaject Water for Injection 5 mL Injection 5mlx100's 091422 PKR 1,104.14 PKR 2.21/mL 11% above median
Aquaject Water for Injection 10 mL presentation Injection / diluent 1's 094675 PKR 18.00 PKR 18.00/vial/unit 23% below median
Aquaject Water for Injection 10 mL Injection 100's 094675 PKR 1,656.21 PKR 16.56/vial/unit 28% below median
Axitrim Ceftriaxone 1 g Injection 1's 084519 PKR 547.65 PKR 547.65/vial/unit 9% below median
Axitrim Ceftriaxone 500 mg Injection 1's 084520 PKR 290.03 PKR 290.03/vial/unit 12% below median
Axitrim Ceftriaxone 500 mg IM injection 1's 084521 PKR 290.03 PKR 290.03/vial/unit 12% below median
Axitrim Ceftriaxone 1 g Injection 1's 084522 PKR 547.65 PKR 547.65/vial/unit 9% below median
Axitrim Ceftriaxone 250 mg Injection 1's Vial 088510 PKR 172.31 PKR 172.31/vial/unit 10% below median
Axitrim Ceftriaxone 250 mg Injection 1's Vial 088511 PKR 172.31 PKR 172.31/vial/unit 10% below median
Axitrim Ceftriaxone 2 g Injection 1's 105764 PKR 717.51 PKR 717.51/vial/unit 12% below median
Azdime Ceftazidime 250 mg Injection 1's 084515 PKR 147.49 PKR 147.49/vial/unit 8% below median
Azdime Ceftazidime 500 mg Injection 1's 084516 PKR 224.36 PKR 224.36/vial/unit 8% below median
Azdime Ceftazidime 1 g Dry injection 1's 084517 PKR 421.42 PKR 421.42/vial/unit No comparator
Cefivar Cefixime 400 mg Capsule 5’s 086346 PKR 520.25 PKR 104.05/capsule 8% below median
Cefivar Dry Cefixime 100 mg/5 mL Dry suspension 30ml 086348 PKR 290.33 PKR 9.68/mL 8% below median
Cefivar-DS Dry Cefixime 200 mg/5 mL Dry suspension 30ml 086347 PKR 355.30 PKR 11.84/mL 8% below median
Cefotec Cefotaxime 500 mg Injection 1's 084518 PKR 146.86 PKR 146.86/vial/unit 8% below median
Cefotec Cefotaxime 1 g Injection 1's Vial 088512 PKR 264.13 PKR 264.13/vial/unit 8% below median
Cefotec Cefotaxime 250 mg Dry powder for IV/IM injection 1's 100638 PKR 102.37 PKR 102.37/vial/unit 8% below median
CM-Vir Valganciclovir 450 mg Tablet 60's 103547 PKR 120,443.05 PKR 2,007.38/tablet 8% below median
Cu-Iodide Potassium iodide 130 mg Tablet 20's 111865 PKR 50.09 PKR 2.50/tablet 7% below median
Cu-Iodide Potassium iodide 65 mg Tablet 20's 111866 PKR 36.30 PKR 1.82/tablet 9% below median
Cuket Ketamine 50 mg Injection 10ml 106961 PKR 175.39 PKR 17.54/mL 28% below median
Culex Cephalexin 500 mg Capsule 12’s 084531 PKR 341.22 PKR 28.44/capsule 8% below median
Culex Cephalexin 250 mg Capsule 12’s 084533 PKR 174.02 PKR 14.50/capsule 8% below median
Culex Cephalexin 125 mg/5 mL Suspension 60ml 085137 PKR 100.66 PKR 1.68/mL 10% below median
Culex Cephalexin 250 mg/5 mL Suspension 60ml 085138 PKR 174.02 PKR 2.90/mL 12% below median
Culimus Tacrolimus 1 mg Capsule 50's 101653 PKR 4,135.41 PKR 82.71/capsule 15% below median
Culimus Tacrolimus 0.5 mg Capsule 30's 101654 PKR 1,488.75 PKR 49.63/capsule 14% below median
Culimus Tacrolimus 0.5 mg Capsule 10's 101654 PKR 539.40 PKR 53.94/capsule 6% below median
Cunesfin Clomifene citrate 50 mg Tablet 10's 116427 PKR 412.16 PKR 41.22/tablet Near median
Cunnocip Ciprofloxacin 500 mg Tablet 10's 103318 PKR 366.81 PKR 36.68/tablet 14% below median
Cunnocip Ciprofloxacin 250 mg Tablet 10's 103319 PKR 221.79 PKR 22.18/tablet 13% below median
Cunnomide Thalidomide 50 mg Capsule 10's 101655 PKR 895.70 PKR 89.57/capsule 6% above median
Cunnzole Letrozole 2.5 mg Tablet 30's 103322 PKR 11,674.21 PKR 389.14/tablet Near median
Cunnzole Letrozole 2.5 mg Tablet 1's 103322 PKR 389.14 PKR 389.14/tablet Near median
Cuntrizole Clotrimazole 500 mg Vaginal tablet 1’s 116429 PKR 122.12 PKR 122.12/tablet 6% below median
Cuntrizole Clotrimazole 100 mg Vaginal tablet 6's 116439 PKR 114.49 PKR 19.08/tablet 9% below median
Cutrax Tranexamic acid 500 mg/5 mL Injection 10's 094673 PKR 1,450.17 PKR 145.02/vial/unit 8% below median
Cutrax Tranexamic acid 250 mg/5 mL Injection 10's 108351 PKR 730.27 PKR 73.03/vial/unit 19% above median
Cuziper Bisoprolol fumarate 2.5 mg Tablet 14's 105785 PKR 53.06 PKR 3.79/tablet 11% below median
Cuziper Bisoprolol fumarate 5 mg Tablet 20's 105792 PKR 199.31 PKR 9.97/tablet 18% below median
Cuziper Bisoprolol fumarate 10 mg Tablet 20's 105793 PKR 358.76 PKR 17.94/tablet 19% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Cunningham Pharmaceuticals (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/cunningham-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.